by admin | May 4, 2024 | Article
April 29, 2024 – Lupus Canada is pleased to share that Benlysta (indication Lupus Nephritis) is listed in Ontario effective April 17, 2024. SUMMARY OF PRODUCT CHANGES We are pleased to provide you with the Summary of Changes – April 2024 to Edition No. 43 of...
by admin | May 4, 2024 | Article
April 23, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in PEI effective April 23, 2024. For more information, please visit the PEI Pharmacare Program website.
by admin | May 4, 2024 | Article
March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024. For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf
by admin | May 4, 2024 | Article
March 21, 2024 – Lupus Canada is honoured to support the Dr. Murray B. Urowitz Chair in Lupus Research. For over 50 years, Dr. Murray Urowitz led the world in lupus diagnosis, treatment, research and education. The Dr. Murray B. Urowitz Chair in Lupus Research...
by admin | May 4, 2024 | Article
March 25, 2024 – The William Birchall Foundation has donated $25,000 in 2024 in support of the Lupus Canada Scholarship program. The 2024 Lupus Canada William Birchall Foundation Scholarship will be offering ten (10) one-time scholarships of $2,500 CAD to...
